Feature Reviews in Gene and Cell Therapy

Dear Colleagues,

Gene and Cell Therapy involves two aspects: gene therapy and cell therapy. Gene therapy is the use of genetic material in the treatment or prevention of disease. The transferred genetic material changes how a single protein or group of proteins is produced by the cell. Cell therapy is a method that uses the patient's own or donor cells to stimulate an immune response or cell regeneration to kill pathogens and tumor cells. It includes immune cell therapy, stem cell therapy, and somatic cell therapy.

In the past few decades, the research on gene and cell therapy has developed rapidly and this is now emerging as an alternative therapy for many diseases. We aim to showcase the gene and cell therapy field in our Biomedicines journal by launching this Special Issue. Review articles on topics related (but not limited) to the above-mentioned areas (including reviews on gene and cell therapy in tumors, genetic diseases, cardiovascular diseases, autoimmune diseases, and some rare diseases) are all welcome. Reviews have to most up-to-date and focus on the development of recent 10 years.

Dr. Carminia Maria Della Corte
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• immunotherapy
• immunogenetics
• stem cell therapy
• CAR-T cell therapy
• tissue engineering and regenerative medicine
• genomic medicine
• animal models
• viral vector
• bacterial vector
• genome editing
• plasmid DNA
• RNA therapeutics